FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

LINDA APUZZO

Research Profile

Living Beings

HIV-1

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Genes & Molecular Sequences

Genes, gag

Co-author Network

Publications

TOP 3
Christine M Durand; Karen A O'Connell; LINDA APUZZO; Susan J Langan; Hejab Imteyaz; Aima A Ahonkhai; Christina M Ceccato; Thomas M Williams; Joseph B Margolick; Joel N Blankson
HIV-1 Gag evolution in recently infected human leukocyte antigen-B*57 patients with low-level viremia.
Joseph B Margolick; Hejab Imteyaz; Joel E Gallant; Susan J Langan; Jason B Dinoso; Janet D Siliciano; Joel N Blankson; Tricia L Nilles; Kendall A Smith; LINDA APUZZO
Prolonged viral suppression without therapy in an HIV-1 seroconverter following early antiretroviral therapy and daily interleukin-2.
Karen A O'Connell; Jie Xu; Anna P Durbin; LINDA APUZZO; Hejab Imteyaz; Thomas M Williams; Stuart C Ray; Joseph B Margolick; Robert Siliciano; Joel N Blankson
HIV-1 evolution following transmission to an HLA-B*5801-positive patient.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of LINDA APUZZO (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Christine M Durand; Karen A O'Connell; LINDA APUZZO; Susan J Langan; Hejab Imteyaz; Aima A Ahonkhai; Christina M Ceccato; Thomas M Williams; Joseph B Margolick; Joel N Blankson
HIV-1 Gag evolution in recently infected human leukocyte antigen-B*57 patients with low-level viremia.
AIDS (London, England) 2010;24(15):2405-8.
2010: Joseph B Margolick; Hejab Imteyaz; Joel E Gallant; Susan J Langan; Jason B Dinoso; Janet D Siliciano; Joel N Blankson; Tricia L Nilles; Kendall A Smith; LINDA APUZZO
Prolonged viral suppression without therapy in an HIV-1 seroconverter following early antiretroviral therapy and daily interleukin-2.
AIDS (London, England) 2010;24(6):932-5.
2009: Karen A O'Connell; Jie Xu; Anna P Durbin; LINDA APUZZO; Hejab Imteyaz; Thomas M Williams; Stuart C Ray; Joseph B Margolick; Robert Siliciano; Joel N Blankson
HIV-1 evolution following transmission to an HLA-B*5801-positive patient.
The Journal of infectious diseases 2009;200(12):1820-4.
2009: LINDA APUZZO; Florin Vaida; Joel E Gallant; Karin B Ernstrom; Susan J Little; Jean-Pierre Routy; Ann C Collier; Brian Conway; Martin H Markowitz; Frederick Hecht; Bruce D Walker; Elizabeth Connick; Joseph B Margolick
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection.
Journal of acquired immune deficiency syndromes (1999) 2009;50(3):267-75.
2003: Walter III Royal; B Dupont; D McGuire; L Chang; Karl Goodkin; T Ernst; M Judith Donovan Post; D Fish; G Pailloux; H Poncelet; M Concha; LINDA APUZZO; E Singer
Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.
Journal of neurovirology 2003;9(3):411-9.
2003: J Brooks Jackson; Scott Barnett; Estelle Piwowar-Manning; LINDA APUZZO; Charles Raines; Craig W Hendrix; Fayez M Hamzeh; Joel E Gallant
A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk.
AIDS (London, England) 2003;17(4):547-53.
2000: Charles Raines; Charles Flexner; Eugene Sun; ME Heath-Chiozzi; R H Lewis; C Fields; Carl O Deetz; LINDA APUZZO; Susan H Eshleman; J Brooks Jackson; Joel E Gallant
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks.
Journal of acquired immune deficiency syndromes (1999) 2000;25(4):322-8.
1995: James P Dunn; M W MacCumber; M S Forman; PATRICIA CHARACHE; LINDA APUZZO; Douglas A Jabs
Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
American journal of ophthalmology 1995;119(5):587-96.